Level 2 - Clinical Transition Structuring
Are you entering CRO engagement with a structured framework and clear negotiation boundaries?
At this stage, biotech teams often ask:
Are we operationally structured to engage a CRO?
Is our governance model clear before external negotiation?
Are we aligned internally on decision authority?
Do we understand the financial exposure of outsourcing?
Are we ready to launch an RFP process with clarity?
Is this stage familiar?
Preparing to evaluate CRO partners?
Run a 2-minute CRO readiness check before starting vendor selection.
Governance & Decision Framework
Internal decision authority prior to CRO engagement
Board vs management escalation triggers
External advisory integration
Clinical Development Alignment
Protocol maturity vs outsourcing timing
Operational feasibility assumptions
Study complexity risk profile
Budget & Financial Positioning
Capital allocation strategy prior to CRO launch
Financial flexibility under different trial scenarios
Pre-RFP budget positioning benchmark
What We Structure
CRO Engagement Strategy
Vendor model definition (global vs niche vs hybrid)
Geographic and therapeutic alignment
Oversight expectations prior to vendor selection
Negotiation Readiness
Clear definition of non-negotiables
Flexibility thresholds prior to CRO discussions
Alignment on risk tolerance and capital exposure
Risk Exposure Mapping
Asset complexity risks
Operational dependency risks
Financial exposure triggers
Executive-level diagnostic of the situation and structured assessment across six dimensions:
What You Receive
CRO Matching & Shortlisting
Structured vendor evaluation criteria to guide targeted and disciplined CRO outreach aligned with protocol scope, governance model, and organizational maturity.
Protocol-Aligned Preliminary Budget Benchmark
Independent financial orientation aligned with protocol scope, outsourcing structure and capital allocation strategy prior to formal RFP launch.
RFP Structuring & Guidance
Framework for designing and launching an RFP process with clear scope definition, evaluation criteria, and internal alignment.
Governance & Contractual Boundary Framework
Defined internal decision pathways and preliminary contractual risk criteria to establish negotiation boundaries prior to entering vendor discussions.
Executive Transition Alignment Session
Strategic preparation discussion ensuring internal alignment before external negotiation begins.
Level 2 ensures your organization enters CRO engagement structurally aligned, financially positioned, and strategically prepared.
Engagement scope and investment vary depending on trial complexity and stage. All collaborations begin with a structured exploratory discussion.
Get in touch
Discuss your clinical transition with an independent perspective.
Contact
© 2026. Biotech Advisory Lab. All rights reserved.
Legal
